Skip to main content
All lobbying filings

Evonik Corporation

Evonik Corporation filed a Q2 report for Evonik Corporation on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Evonik Corporation · Manufacturer of specialty chemicals

As filed: EVONIK CORPORATION for EVONIK CORPORATION.

All filings by Evonik Corporation · Everything Evonik Corporation has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7

Issues related to the Administrations tariff actions and related Congressional oversight

Issues related to TSCA reform H.R.0000/S.0000 (discussion drafts) - To reauthorize the Toxic Substances Control Act, and for other purposes Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts D4 Draft Risk Evaluation

Make American Healthy Again (MAHA) GRAS issue

H.R.9171/S.0000 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027 FY27 Appropriations Actions

General issues related to corporate tax

Issues related to various trade agreement discussions USMCA Review Process

Issues related to the Surface Transportation Board (STB) and rail mergers

 Bills named in this filing 3
  • 119-HR-0000
    Not yet in our database
  • 119-S-0000
    Not yet in our database
  • H.R. 9171
    Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem